Ontology highlight
ABSTRACT: Background and objective
The early results of the American College of Surgeons Oncology Group (ACOSOG) Z0011 trial demonstrated no difference in locoregional recurrence for patients with positive sentinel lymph nodes (SLNs) randomized either to axillary lymph node dissection (ALND) or sentinel lymph node dissection (SLND) alone. We now report long-term locoregional recurrence results.Methods
ACOSOG Z0011 prospectively examined overall survival of patients with SLN metastases undergoing breast-conserving therapy randomized to undergo ALND after SLND or no further axillary specific treatment. Locoregional recurrence was prospectively evaluated and compared between the groups.Results
Four hundred forty-six patients were randomized to SLND alone and 445 to SLND and ALND
SUBMITTER: Giuliano AE
PROVIDER: S-EPMC5070540 | biostudies-literature | 2016 Sep
REPOSITORIES: biostudies-literature